Skip to content
Study details
Enrolling now

Ketamine-Assisted Group Therapy Trial

Juliana Zambrano, MD, MPH
NCT IDNCT06597695ClinicalTrials.gov data as of Apr 2026
Phase

Phase 1/2

Target enrollment

10

Study length

about 11 months

Ages

18–64

Locations

1 site in MA

What this study is about

Researchers are testing a new treatment called ketamine-assisted psychotherapy for people who speak Spanish and have depression. The goal is to see if it's safe, feasible, and might help with their depression. The trial will last about 343 days.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Ketamine-assisted psychotherapy

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

anesthetic (NMDA receptor antagonist; induces dissociative anesthesia and analgesia)

Endpoints

Secondary: Investigate the preliminary efficacy of the group-based ketamine intervention on psychiatric symptoms, wellbeing, and health behaviors among Spanish-speaking participants with depression.

Body systems

Psychiatry / Mental Health